B cell development pathways

Annual Review of Immunology

Volumn 19, Issue , 2001, Pages 595-621

  Hardy, R R ^a   Hayakawa, K ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

B 1 B cells; CD5+ B cells; Pre BCR; Selection

Indexed keywords

B LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; B LYMPHOCYTE; BONE MARROW; CELL LINEAGE; CELL MATURATION; HEMATOPOIESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD5; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BONE MARROW; CELL DIFFERENTIATION; CELL LINEAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REARRANGEMENT, B-LYMPHOCYTE; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; MICE; ORGAN SPECIFICITY; PERITONEAL CAVITY; RECEPTORS, ANTIGEN, B-CELL;

EID: 0035056376     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.19.1.595     Document Type: Review

References (165)

1. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta
2. Stromal-cell and cytokine-dependent lymphocyte clones which span the pre-B- to B-cell transition
3. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse
4. In-vitro analyses of mechanisms of B-cell development
5. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells
6. A developmental switch in B lymphopoiesis
7. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver
8. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies
9. Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ. Recombination at the IgH locus
10. A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly
11. + B cells:the Ly-1 B lineage?
12. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice
13. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
14. Surrogate light chain in B cell development
15. Murine B lymphopoiesis: Towards a unified model
16. Identification of clonogenic common lymphoid progenitors in mouse bone marrow
17. Commitment to the B lymphoid lineage occurs before DH-JH recombination
18. Identification of the earliest B lineage stage in mouse bone marrow
19. +)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow
20. + cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors
21. Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events
22. Distribution of Ly-6C on lymphocyte subsets: I. Influence of allotype on T lymphocyte expression
23. Early B-cell development in the mouse: Insights from mutations introduced by gene targeting
24. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB
25. PanfE2A expression precedes immunoglobulin heavy-chain expression during B lymphopoiesis in nontransformed cells, and Pan/E2A proteins are not detected in myeloid cells
26. Both E12 and E47 allow commitment to the B cell lineage
27. Failure of B-cell differentiation in mice lacking the transcription factor EBF
28. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer
29. The macrophage and B cell-specific transcription factor PU. 1 is related to the ets oncogene
30. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
31. Targeted disruption of the PU. 1 gene results in multiple hematopoieric abnormalities
32. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation
33. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
34. Long-term in vivo reconstitution of T-cell development by Pax5- deficient B-cell progenitors
35. Defective DNA-dependent protein kinase activity is linked to V(D)J. Recombination and DNA repair defects associated with the murine scid mutation
36. Development of B-lineage cells in the bone marrow of scid/scid mice following the introduction of functionally rearranged immunoglobulin transgenes
37. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J. Recombination
38. RAG-2deficient mice lack mature lymphocytes owing to inability to initiate V(D)J. Rearrangement
39. RAG-1-deficient mice have no mature B and T lymphocytes
40. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice
41. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation
42. The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain
43. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines
44. A critical role of lambda 5 protein in B cell development
45. Regulation of an early developmental checkpoint in the B cell pathway by Ig beta
46. Mice lacking TdT: Mature animals with an immature lymphocyte repertoire
47. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes
48. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines
49. Surrogate light chain-dependent selection of Ig heavy chain V regions
50. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains
51. The roles of preB cell receptor in early B cell development and its signal transduction
52. Heavy chain V gene-specific elimination of B cells during the pre-B cell to B cell transition
53. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor
54. Development of B-1 cells: Segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression
55. + (CD5) B cells
56. VH CDR3-dependent positive selection of murine VH12-expressing B cells in the neonate
57. The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor
58. Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity
59. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
60. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens
61. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death
62. Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody
63. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
64. Peripheral deletion of self-reactive B cells
65. Receptor editing in self-reactive bone marrow B cells
66. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen
67. Receptor editing in a transgenic mouse model: Site, efficiency, and role in B cell tolerance and antibody diversification
68. Receptor editing occurs frequently during normal B cell development
69. Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells
70. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice
71. B lymphocytes may escape tolerance by revising their antigen receptors
72. Receptor editing: An approach by autoreactive B cells to escape tolerance
73. Deletion and editing of B cells that express antibodies to DNA
74. The site and stage of anti-DNA B-cell deletion
75. Light chain replacement: A new model for antibody gene rearrangement
76. Editing disease-associated autoantibodies
77. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice
78. B-1 cell definition
79. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity
80. Cell surface antigens expressed by subsets of pre-B cells and B cells
81. The molecular characterization of the fetal stem cell marker AA4
82. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy Chain rearrangement
83. Rearrangement of lambda light chain genes in mature B cells in vitro and in vivo. Function of reexpressed recombination-activating gene (RAG) products
84. V(D)J recombinase activity in a subset of germinal center B lymphocytes
85. Rapid elimination of mature autoreactive B cells demonstrated by Cre-induced change in B cell antigen receptor specificity in vivo
86. B cell subpopulations identified by two-color fluorescence analysis
87. The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor
88. Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics
89. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immune developmental intermediate in the production of long-lived marrow-derived B cells
90. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice
91. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies
92. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells
93. Differential development of progenitor activity for three B-cell lineages
94. Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice
95. Regulated expression of globin chains and the erythroid transcription factor GATA-1 during erythropoiesis in the developing mouse
96. Hemoglobin switching during murine embryonic development: Evidence for two populations of embryonic erythropoietic progenitor cells
97. Role of homology-directed recombination: Predominantly productive rearrangements of Vh81X in newborns but not in adults
98. Analysis of homology-directed recombination in VDJ. Junctions from cytoplasmic Ig- pre-B cells of newborn mice
99. Terminal deoxynucleotidyl transferase expression during neonatallife alters D(H) reading frame usage and Ig-receptor-dependent selection of V regions
100. Increased junctional diversity in fetal B cells results in a loss of protective antiphosphorylcholine antibodies in adult mice
101. Frequency of VH81x usage during B cell development: Initial decline in usage is independent of Ig heavy chain cell surface expression
102. V(H) repertoire maturation during B cell development in vitro: Differential selection of Ig heavy chains by fetal and adult B cell progenitors
103. Rearrangement and selection of VH11 in the Ly- 1 B cell lineage
104. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family
105. Differential effect of an Ig mu transgene on development of pre-B cells in fetal and adult SCID mice
106. Clonotypic analysis of the fetal B cell repertoire:evidence for an early and predominant expression of idiotypes associated with the VH 36- 60 family
107. In vivo suppression of perinatal multispecific B cells results in a distortion of the adult B cell repertoire
108. B cell development in mice
109. Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: Two B-cell activation pathways
110. B-1 cells:-orthodox or conformist?
111. Development and function of B-1 cells
112. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes
113. B cell development and activation defects resuiting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice
114. The role of complement and complement receptors in induction and regulation of immunity
115. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav
116. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene
117. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase
118. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha
119. Defective B cell development and function in Btk-deficient mice
120. oct-2 gene disruption eliminates the peritoneal B-1 lymphocyte lineage and attenuates B-2 cell maturation and function
121. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis
122. Vav regulates peptide-specific apoptosis in thymocytes
123. CD19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav
124. Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment
125. Hyperresponsive B cells in CD22-deficient mice
126. A double-edged kinase Lyn: A positive and negative regulator for antigen receptor-mediated signals
127. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
128. Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice
129. + B cells in viable motheaten and normal mice
130. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation
131. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
132. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice
133. CD19 regulates B lymphocyte signaling thresholds critical for the development of B- 1 lineage cells and autoimmunity
134. + B cells both in vivo and in vitro
135. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice
136. + T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope
137. Natural autoantibodies to thymocytes: Origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein
138. Secondary V(D)J. Recombination in B-1 cells
139. Bc1-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
140. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ. mice
141. A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice
142. Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice
143. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development
144. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells
145. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells
146. CD5 maintains tolerance in anergic B cells
147. Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co-mitogenic signalling
148. Structural analysis of the CD5 antigen-expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1
149. Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells
150. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5
151. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand
152. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: Involvement of SH2-containing phosphotyrosine phosphatase SHP-1
153. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Racl in human mature T lymphocytes
154. Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II
155. Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: Implication on TCR/CD3-mediated activation
156. 2+/calmodulin-dependent kinase IIdelta
157. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase
158. Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis
159. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells
160. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice
161. Requirement of IL-5 for induction of autoimmune hemolytic anemia in anti-red blood cell autoantibody transgenic mice
162. Involvement of IL-10 in induction of autoimmune hemolytic anemia in antierythrocyte Ig transgenic mice
163. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment
164. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population
165. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis